These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8307059)
1. Multiple sclerosis: new therapeutic concepts or better use of old drugs? Clanet M Eur Neurol; 1993; 33(6):401-2. PubMed ID: 8307059 [No Abstract] [Full Text] [Related]
2. Interferon beta-1b for the treatment of multiple sclerosis. Petri T; Weber-Diehl F J Biotechnol; 1995 Nov; 43(1):74-5. PubMed ID: 8573325 [No Abstract] [Full Text] [Related]
8. MRI and clinical activity in MS patients after terminating treatment with interferon beta-1b. Richert ND; Zierak MC; Bash CN; Lewis BK; McFarland HF; Frank JA Mult Scler; 2000 Apr; 6(2):86-90. PubMed ID: 10773853 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis. Webster GF; Knobler RL; Lublin FD; Kramer EM; Hochman LR J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):365-7. PubMed ID: 8655728 [TBL] [Abstract][Full Text] [Related]
10. [Interferon-beta in treatment of relapsing multiple sclerosis]. Hartung HP; Hohlfeld R Nervenarzt; 1994 Feb; 65(2):139-45. PubMed ID: 8164769 [No Abstract] [Full Text] [Related]
11. New tools for biotech product development. Quay S Biotechnology (N Y); 1995 Apr; 13(4):319-20. PubMed ID: 9678946 [No Abstract] [Full Text] [Related]
13. Lethal capillary leak syndrome after a single administration of interferon beta-1b. Schmidt S; Hertfelder HJ; von Spiegel T; Hering R; Harzheim M; Lassmann H; Deckert-Schlüter M; Schlegel U Neurology; 1999 Jul; 53(1):220-2. PubMed ID: 10408566 [TBL] [Abstract][Full Text] [Related]
15. Role of interferons in demyelinating disease. Johnson KP J Neural Transm Suppl; 1997; 49():111-5. PubMed ID: 9266420 [TBL] [Abstract][Full Text] [Related]
16. Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure. Stone LA; Frank JA; Albert PS; Bash CN; Calabresi PA; Maloni H; McFarland HF Neurology; 1997 Sep; 49(3):862-9. PubMed ID: 9305355 [TBL] [Abstract][Full Text] [Related]
17. Interferon beta-1B--hope or hype? Drug Ther Bull; 1996 Feb; 34(2):9-11. PubMed ID: 8819985 [No Abstract] [Full Text] [Related]